[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.65.30. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
March 13, 2002

News About Neuroprotectants for the Treatment of Stroke

Author Affiliations
 

Not Available

Not Available

JAMA. 2002;287(10):1253-1254. doi:10.1001/jama.287.10.1253-JMN0313-2-1

San Antonio, Tex—Scientists have achieved success using neuroprotectant drugs to limit stroke injury in animal models, but transferring these outcomes to humans has been disappointing.

Dozens of clinical trials have failed to show efficacy for a variety of neuroprotectants, but researchers are not giving up. They theorize that the lack of positive results in humans may be due to giving improper dosages, studying too broad a population in clinical trials, and allowing delays in administering the drugs.

First Page Preview View Large
First page PDF preview
First page PDF preview
×